From initial feasibility to final study closure, we streamline processes, proactively identify risks, and ensure adaptability, so your study maintains momentum and achieves success.
Accelerate your research, not just your startup. AcceleROUTE™ is our proprietary methodology, designed to optimize every phase of your clinical trial, from feasibility to closure. We ensure speed, quality, and budget control remain paramount throughout the entire process.
Unlike CROs that focus solely on startup, AcceleROUTE™ integrates four critical phases into a comprehensive approach. It begins with Study Oversight and Management, ensuring administrative integrity and compliance through streamlined processes and proactive risk mitigation. This is followed by Startup Acceleration, which rapidly activates sites by efficiently allocating resources, negotiating contracts, and managing vendors. The next phase, Study Conduct Optimization, maintains trial momentum through proactive monitoring, data quality oversight, and adaptable solutions. Finally, Efficient Study Closure is achieved by planning for timely database lock and reporting while managing data integrity.
The colision of information provided to us by both patients and care givers is what makes our approach unique. Patients are central to our approach, which allows us to better both their experience and your trial outcomes significantly. That is why we like to refer to ProPATIENT Solutions™ as our first-hand tool.